Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions

被引：1

作者：

Srivastava, Rajkamal ^{[1
,2
]}

Lesser, Cammie F. ^{[1
,2
,3
,4
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Bacterial Pathogenesis, Dept Med, Div Infect Dis, Boston, MA 02114 USA

[2] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA

[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

[4] Ragon Inst Harvard & MIT, Cambridge, MA 02139 USA

来源：

MICROBIAL BIOTECHNOLOGY | 2024年 / 17卷 / 11期

基金：

美国国家卫生研究院;

关键词：

engineered bacteria; live biotherapeutic products; smart microbes; COLI NISSLE 1917;

D O I：

10.1111/1751-7915.70057

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Live biotherapeutic products (LBPs), including engineered bacteria, are rapidly emerging as potential therapeutic interventions. These innovative therapies can serve as live in situ drug delivery platforms for the direct deposition of therapeutic payloads, including complex biologics, at sites of disease. This approach offers a platform likely to enhance therapeutic efficacy and decrease off-target side effects. LBPs also can likely be distributed at a relatively low price point, as their production can be economically scaled up. LBPs represent an exciting new means for ensuring healthy lives and promoting well-being for all ages, aligning with the World Health Organization's sustainable development goal 3.

引用

页数：8

共 46 条

[31] Direct Synthesis of Photosensitizable Bacterial Cellulose as Engineered Living Material for Skin Wound Repair
Liu, Xingang
Wu, Min
Wang, Meng
Hu, Qida
Liu, Jingjing
Duan, Yukun
Liu, Bin
ADVANCED MATERIALS, 2022, 34 (13)
[32] Immobilization of functional nano-objects in living engineered bacterial biofilms for catalytic applications
Wang, Xinyu
Pu, Jiahua
Liu, Yi
Ba, Fang
Cui, Mengkui
Li, Ke
Xie, Yu
Nie, Yan
Mi, Qixi
Li, Tao
Liu, Lingli
Zhu, Manzhou
Zhong, Chao
NATIONAL SCIENCE REVIEW, 2019, 6 (05) : 929 - 943
[33] Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Chaves, Luiz Paulo
Melo, Camila Morais
Saggioro, Fabiano Pinto
Reis, Rodolfo Borges dos
Squire, Jeremy Andrew
GENES, 2021, 12 (12)
[34] Staphylococcus aureus and Pseudomonas aeruginosa infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics
Shah, Shalini
Wozniak, Rachel A. F.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[35] Bacterial Extracellular Vesicles and the Gut-Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics
Pirolli, Nicholas H.
Bentley, William E.
Jay, Steven M.
ADVANCED BIOLOGY, 2021, 5 (07):
[36] Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
Tobeh, Nour S.
Bruce, Kimberley D.
FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
[37] Hierarchically Engineered Self-Adaptive Nanoplatform Guided Intuitive and Precision Interventions for Deep-Seated Glioblastoma
Cheng, Wei
Qu, Haijing
Yang, Jiaojiao
Chen, Han
Pan, Yuqing
Duan, Zhiran
Xue, Xiangdong
ACS NANO, 2025, 19 (01) : 557 - 579
[38] Spontaneous bacterial and fungal infections in genetically engineered mice: Is Escherichia coli an emerging pathogen in laboratory mouse?
Benga, Laurentiu
Benten, W. Peter M.
Engelhardt, Eva
Gougoula, Christina
Sager, Martin
BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2015, 128 (7-8): : 278 - 284
[39] Lipid-Encapsulated Engineered Bacterial Living Materials Inhibit Cyclooxygenase II to Enhance Doxorubicin Toxicity
Jiang, Ning
Ding, Wanqing
Zhu, Xiaojuan
Chen, Jianshu
Yang, Lin
Yi, Xiaoping
Zhuang, Yingping
Qian, Jiangchao
Huang, Jiaofang
BIODESIGN RESEARCH, 2024, 6
[40] United under stress: High-speed transport network emerging at bacterial living edge
Wen, Xiaodong
Feng, Jingjing
Sang, Yuqian
Ge, Feng
Chate, Hugues
He, Yan
FUNDAMENTAL RESEARCH, 2024, 4 (03): : 563 - 569

← 1 2 3 4 5 →